Salkeld G - Search Results

1

Cost-effectiveness analysis of screening by faecal occult blood testing for colorectal cancer in Australia.

Salkeld G, Young G, Irwig L, Haas M, Glasziou P. Salkeld G, et al. Aust N Z J Public Health. 1996 Apr;20(2):138-43. doi: 10.1111/j.1753-6405.1996.tb01807.x. Aust N Z J Public Health. 1996. PMID: 8799087 Free article.

2

High participation rates are not necessary for cost-effective colorectal cancer screening.

Howard K, Salkeld G, Irwig L, Adelstein BA. Howard K, et al. Among authors: salkeld g. J Med Screen. 2005;12(2):96-102. doi: 10.1258/0969141053908276. J Med Screen. 2005. PMID: 15949121

3

The potential benefits and harms of screening for colorectal cancer.

Towler B, Irwig L, Glasziou P, Haas M, Plunkett A, Salkeld G. Towler B, et al. Among authors: salkeld g. Aust J Public Health. 1995 Feb;19(1):24-8. doi: 10.1111/j.1753-6405.1995.tb00292.x. Aust J Public Health. 1995. PMID: 7734588

4

Cost-effectiveness of mammographic screening in Australia.

Carter R, Glasziou P, van Oortmarssen G, de Koning H, Stevenson C, Salkeld G, Boer R. Carter R, et al. Among authors: salkeld g. Aust J Public Health. 1993 Mar;17(1):42-50. doi: 10.1111/j.1753-6405.1993.tb00103.x. Aust J Public Health. 1993. PMID: 8357894

5

Benefits, harms and costs of screening mammography in women 70 years and over: a systematic review.

Barratt AL, Les Irwig M, Glasziou PP, Salkeld GP, Houssami N. Barratt AL, et al. Med J Aust. 2002 Mar 18;176(6):266-71. doi: 10.5694/j.1326-5377.2002.tb04405.x. Med J Aust. 2002. PMID: 11999259 Review.

6

Fifteen years of bowel cancer screening policy in Australia: putting evidence into practice?

Flitcroft KL, Salkeld GP, Gillespie JA, Trevena LJ, Irwig LM. Flitcroft KL, et al. Med J Aust. 2010 Jul 5;193(1):37-42. doi: 10.5694/j.1326-5377.2010.tb03739.x. Med J Aust. 2010. PMID: 20618113

7

Colorectal cancer screening: why immunochemical fecal occult blood tests may be the best option.

Flitcroft KL, Irwig LM, Carter SM, Salkeld GP, Gillespie JA. Flitcroft KL, et al. BMC Gastroenterol. 2012 Dec 29;12:183. doi: 10.1186/1471-230X-12-183. BMC Gastroenterol. 2012. PMID: 23272939 Free PMC article. Review.

8

Feasibility study of the early detection and treatment of renal disease by mass screening.

Craig JC, Barratt A, Cumming R, Irwig L, Salkeld G. Craig JC, et al. Among authors: salkeld g. Intern Med J. 2002 Jan-Feb;32(1-2):6-14. Intern Med J. 2002. PMID: 11783681

9

Informed choice for screening: implications for evaluation.

Irwig L, McCaffery K, Salkeld G, Bossuyt P. Irwig L, et al. Among authors: salkeld g. BMJ. 2006 May 13;332(7550):1148-50. doi: 10.1136/bmj.332.7550.1148. BMJ. 2006. PMID: 16690676 Free PMC article. Review.

10

HPV triage testing or repeat Pap smear for the management of atypical squamous cells (ASCUS) on Pap smear: is there evidence of process utility?

Howard K, Salkeld G, McCaffery K, Irwig L. Howard K, et al. Among authors: salkeld g. Health Econ. 2008 May;17(5):593-605. doi: 10.1002/hec.1278. Health Econ. 2008. PMID: 17764095

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121 results

Search Page

Filters